Centene (CNC) Stock Drops After Trump’s Call to Redirect ACA Funds
Centene shares slid 9% after Trump called for ACA funding to go directly to individuals rather than insurance companies.
BTC$62,686.00-1.67%
ETH$1,666.62-3.16%
USDT$0.9987-0.01%
USDC$0.9996-0.01%
XRP$1.10-1.88%
SOL$69.40-3.23%
TRX$0.329-1.01%
FIGR_HELOC$1.03-0.16%
HYPE$61.30-7.24%
DOGE$0.0789-3.56%
USDS$0.9997+0.00%
RAIN$0.0157-2.06%
LEO$9.49-0.84%
ZEC$413.84-6.89%
XLM$0.1911-3.05%
BTC$62,686.00-1.67%
ETH$1,666.62-3.16%
USDT$0.9987-0.01%
USDC$0.9996-0.01%
XRP$1.10-1.88%
SOL$69.40-3.23%
TRX$0.329-1.01%
FIGR_HELOC$1.03-0.16%
HYPE$61.30-7.24%
DOGE$0.0789-3.56%
USDS$0.9997+0.00%
RAIN$0.0157-2.06%
LEO$9.49-0.84%
ZEC$413.84-6.89%
XLM$0.1911-3.05%
Philip Morris, Biogen, and Centene reported quarterly results, with PM and BIIB beating expectations and CNC posting mixed performance.
Centene shares slid 9% after Trump called for ACA funding to go directly to individuals rather than insurance companies.
Centene Corporation's Q2 2025 results revealed a loss per share and revenue figures that diverged from expectations.
Centene Corporation withdrew its 2025 guidance after discovering that Health Insurance Marketplace morbidity trends were significantly higher than expected.
Centene Corporation's first-quarter earnings surpassed expectations, but concerns over rising Medicaid costs led to a drop in its stock price.
Centene Corporation reported strong results in the third-quarter of 2024 with over $42 billion in revenue.
Centene Corporation reports a successful Q4, with a revenue of $39.46 billion and an EPS of $0.45.